At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
SXTP 60 degrees pharmaceuticals, Inc.
Market Closed 11-22 16:00:00 EST
0.9000
+0.0260
+2.97%
盘后0.9000
+0.00000.00%
18:51 EST
High0.9500
Low0.8610
Vol34.69K
Open0.9500
D1 Closing0.8740
Amplitude10.18%
Mkt Cap1.68M
Tradable Cap1.33M
Total Shares1.86M
T/O31.53K
T/O Rate2.34%
Tradable Shares1.48M
P/B--
ROE--
EPS0.00
52wk High--
52wk Low--
P/E--
Dividend--
Div.Yield--
ROA--
H.C. Wainwright Reaffirms Their Hold Rating on 60 Degrees Pharmaceuticals, Inc. (SXTP)
60 Degrees Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the development and commercialization of therapies for the prevention and treatment of infectious diseases in the United States. The company offers Arakoda for malaria preventative treatment. It also engages in the development of Tafenoquine (Arakoda regimen) that is in Phase IIb clinical trial for COVID-19 indications; Tafenoquine, which is in phase IIA clinical trials for babesiosis, fungal pneumonias, and candidiasis disease; and Celgosivir for respiratory viruses and dengue. 60 Degrees Pharmaceuticals, Inc. was founded in 2010 and is based in Washington, District Of Columbia.